Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
EP Vantage
»
Articles
(27)
|
EP Vantage
14
Followers
1
Following
You are currently following EP Vantage
Stop Following
You are no longer following EP Vantage
Profile
Articles (27)
Instablog (6)
Sort by:
Latest
|
Editors' Picks
|
Most Commented
|
Most Popular
J&J Comes Riding to Elan's Rescue
on Jul 03, 2009
•
ELN
,
JNJ
Generic Players Continue to Impress in H1
on Jul 02, 2009
•
ABBI
,
ACL
,
ALO
Cell Genesys: BioSante Sees Something Other than Cash
on Jul 01, 2009
•
BPA
,
CEGE
Smaller Pharma Wins the 'Most Valuable' Race
on Jul 01, 2009
•
ALKS
,
AMGN
,
CELG
Biotech Set to Dominate Drug Industry Growth
on Jun 18, 2009
•
ABT
,
AMGN
,
JNJ
Genentech Seals Roche's Dominance of Oncology Market
on Apr 01, 2009
•
DNA
,
RHHBY.PK
Gilead Follows Its Heart, Sweeps CV Away for $1.4B
on Mar 13, 2009
•
ALPMF.PK
,
CVTX
,
GILD
Will Johnson & Johnson Disrupt SchMerck?
on Mar 12, 2009
•
JNJ
,
MRK
,
SGP
New Wave of Pharma Mergers with Merck - Schering-Plough Deal
on Mar 10, 2009
•
JNJ
,
MRK
,
PFE
Genentech's Bullish Forecasts Are Not in Line with Wall Street
on Mar 05, 2009
•
DNA
,
RHHBY.PK
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
on Feb 13, 2009
•
ARKTF.PK
,
BMY
,
BYERF.PK
La Jolla Drug Failure Leaves Few Options
on Feb 12, 2009
•
BMRN
,
LJPC
Will 2009 Be a Year for Pharma Currency Speculators?
on Feb 02, 2009
•
AZN
,
BAYRY.PK
,
GSK
Pfizer-Wyeth Merger Looks Unwise
on Feb 02, 2009
•
PFE
,
WYE
Ustekinumab PDUFA Could Kick Start Medarex Revival
on Nov 28, 2008
•
MEDX
Human Genome Sciences Awaiting Crucial Albuferon Data
on Nov 14, 2008
•
HGSI
Amylin Facing Crisis of Confidence
on Nov 14, 2008
•
AMLN
Rigel's Punishment May Prove Short-Sighted
on Oct 31, 2008
•
RIGL
Reality Check on the Big Pharma Rumor Mill
on Oct 31, 2008
•
BAYRY.PK
,
BMY
,
JNJ
Tysabri Concerns Continue to Weigh on Biogen, Elan
on Oct 23, 2008
•
BIIB
,
ELN
Ownership of Erbitux Follow-On Is Central to ImClone Takeover
on Sep 13, 2008
•
BMY
,
IMCL
Myriad Genetics Spin-Off Would Be a Welcome Move
on Sep 12, 2008
•
MYGN
Amgen Gets Much Needed Denosumab Boost
on Jul 29, 2008
•
AMGN
Allos Therapeutics Looks Promising Ahead of Crucial 6 Months
on Jul 15, 2008
•
ALTH
AstraZeneca's Acquisition of MedImmune Still Looks Overpriced
on Jun 30, 2008
•
AZN
Big Pharma Pipelines Failing to Meet Expectations
on May 30, 2008
•
ABT
,
AMGN
,
AZN
Chantix Side-Effects May Halt Rare Pfizer Success Story
on May 25, 2008
•
PFE
Articles by Ticker
ABBI
,
ABT
,
ACL
,
ALKS
,
ALO
,
ALPMF.PK
,
ALTH
,
AMGN
,
AMLN
,
ARKTF.PK
,
AZN
,
BAYRY.PK
,
BIIB
,
BMRN
,
BMY
,
BPA
,
BYERF.PK
,
CEGE
,
CELG
,
CEPH
,
CVTX
,
DNA
,
DSKYY.PK
,
ELN
,
ENDP
,
FACT
,
FVRL
,
GILD
,
GSK
,
HGSI
,
HSP
,
HTSUF.PK
,
IMCL
,
INGN
,
IVAC
,
JNJ
,
KG
,
LJPC
,
LLY
,
MEDX
,
MRK
,
MTZXF.PK
,
MYGN
,
MYL
,
NOVN
,
NSRGY.PK
,
NVO
,
NVS
,
PDLI
,
PFE
,
RBXLF.PK
,
RHHBY.PK
,
RIGL
,
ROG
,
SGIOF.PK
,
SGP
,
SNY
,
TKPHF.PK
,
UCBJF.PK
,
VPHM
,
WYE
,
ZGEN
Latest Comments on EP Vantage's Articles
delta 777
on
J&J Comes Riding to Elan's Rescue
: Elan has been suffering a horrible partnership in Tysabri with...
more »
Alphameister
on
Smaller Pharma Wins the 'Most Valuable' Race
: Thank you for a very useful stock screen. Several very appealing...
more »
mandy
on
Chantix Side-Effects May Halt Rare Pfizer Success Story
: "so what"! my 21 year old neice is in a psych ward right now...
more »
satyr
on
Will Johnson & Johnson Disrupt SchMerck?
: Unfortunately for JNJ, the agreement that Centocor struck with SGP...
more »
donzelion
on
New Wave of Pharma Mergers with Merck - Schering-Plough Deal
: Merck is approaching my buying target...this is probably the...
more »
Genentech shareholder
on
Genentech's Bullish Forecasts Are Not in Line with Wall Street
: Genentech made a very persuasive case that it has a very valuable...
more »
Roscat
on
Genentech's Bullish Forecasts Are Not in Line with Wall Street
: No one should underestimate the power and value of the biotechs in...
more »
User 368629
on
Pfizer-Wyeth Merger Looks Unwise
: Agree with Maggot. Recommend not investing in "biosimilars"...
more »
Maggot
on
Pfizer-Wyeth Merger Looks Unwise
: Re Wyeth's "patent cliff", 4 o 7 of the cited drugs are...
more »
kimster
on
Chantix Side-Effects May Halt Rare Pfizer Success Story
: I have tried several times to quit smoking. I have cancer on both...
more »
nova
on
Ustekinumab PDUFA Could Kick Start Medarex Revival
: A company's enterprise value is a bogus number invented by the...
more »
Oldladywho
on
Chantix Side-Effects May Halt Rare Pfizer Success Story
: I smoked for 30 plus years. I quit with Chantix, but I wish I had...
more »
Mandie
on
Chantix Side-Effects May Halt Rare Pfizer Success Story
: I took this medication for about a month and a half. All I...
more »
nova
on
Amylin Facing Crisis of Confidence
: They most serious problem with Amylin is it management. The...
more »
Daniel Haszard
on
Amylin Facing Crisis of Confidence
: Eli Lilly's # 1 cash cow Zyprexa has been overprescribed and...
more »
Latest Comments on EP Vantage's Articles
Latest Comments on EP Vantage's Articles